文献速递慢性肾脏病遗传性与小管间质肾病

常染色体显性多囊肾病中肾脏总体积与eGFR的关系

Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-02-13

本研究基于CRISP和HALT-PKD A队列,按Mayo影像分类分层,采用线性混合模型分析肾脏总体积(TKV)与eGFR的个体内关系。发现各MIC分层内log(TKV)与eGFR呈线性关系,模型预测在1C-1E类中,TKV年增长率每降低1个百分点,eGFR年下降速率减少0.40-0.52 ml/min/1.73m²。该框架可用于界定TKV治疗效应以支持加速审批。

要点

  • 在ADPKD中,log(TKV)与eGFR在各Mayo影像分类内呈线性关系。
  • 1C-1E类中,TKV年增长率每降1个百分点,eGFR年下降减少0.40-0.52 ml/min/1.73m²。
  • 该模型为以TKV为替代终点支持药物加速审批提供框架。

核心结论

  • 在ADPKD中,log(TKV)与eGFR在各Mayo影像分类内存在一致的线性关系。
  • TKV增长速率降低可预测eGFR下降速率的减缓,可用于界定支持加速审批的治疗效应。

研究设计与样本

  • 研究纳入CRISP和HALT-PKD Study A数据集中患者,按Mayo影像分类分层。
  • 采用线性混合模型拟合eGFR,固定效应为log(TKV),随机截距,估计各MIC内平均斜率。

主要发现

  • 在每个Mayo影像分类内,log(TKV)与eGFR呈一致线性关系。
  • 模型预测在1C-1E类中,TKV年增长率每降低1个百分点,eGFR年下降速率减少0.40-0.52 ml/min/1.73m²。

临床怎么用

  • 可利用TKV变化率预测eGFR下降速率的变化,辅助评估ADPKD治疗效应。
  • 该模型框架可用于支持以TKV为替代终点的药物加速审批。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: In autosomal dominant polycystic kidney disease, there is a linear relationship between the log-transformed total kidney volume and eGFR. There is a predictable change in the rate of eGFR decline with reduction in kidney growth rate. This framework can be used to determine treatment effect to support accelerated approval of drugs for polycystic kidney disease. BACKGROUND: Total kidney volume (TKV) is accepted by the US Food and Drug Administration as a surrogate end point that is reasonably likely to predict clinical benefit in autosomal dominant polycystic kidney disease and the most commonly used response biomarker for proof-of-concept intervention trials. However, the magnitude of treatment effect on TKV that would be predictive of a meaningful improvement in a clinical outcome, such as eGFR, is unknown. Inference of this from observational studies has previously been approached by examining interindividual variance in the relationship between TKV and GFR slopes over time. METHODS: We developed a novel approach to modeling the intraindividual relationship between TKV and eGFR. Patients from the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease and Halt Progression of Polycystic Kidney Disease Study A dataset were stratified by Mayo Imaging Class (MIC). Linear mixed models were fitted to eGFR with a fixed effect of log(TKV) and random intercepts, and the average slope within each MIC was estimated. RESULTS: We found that within each MIC, there is a consistent, linear relationship between log(TKV) and eGFR. The model predicts that within classes 1C-1E, for each 1% point per year reduction in TKV growth rate, the rate of eGFR decline would be reduced by 0.40-0.52 ml/min per 1.73 m 2 per year. CONCLUSIONS: We have developed a new model that provides a framework for defining the magnitude of treatment effect on TKV that would support accelerated approval of a drug for autosomal dominant polycystic kidney disease.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Yu ASL, Parker C, Golzarri-Arroyo L, et al. Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2026. PMID: 41686506. doi:10.2215/CJN.0000000992

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。